These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

756 related articles for article (PubMed ID: 12700666)

  • 41. Transforming growth factor-beta-induced growth inhibition in a Smad4 mutant colon adenoma cell line.
    Fink SP; Swinler SE; Lutterbaugh JD; Massagué J; Thiagalingam S; Kinzler KW; Vogelstein B; Willson JK; Markowitz S
    Cancer Res; 2001 Jan; 61(1):256-60. PubMed ID: 11196171
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unique and redundant roles of Smad3 in TGF-beta-mediated regulation of long bone development in organ culture.
    Alvarez J; Serra R
    Dev Dyn; 2004 Aug; 230(4):685-99. PubMed ID: 15254903
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
    Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
    Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen.
    Catalano A; Romano M; Martinotti S; Procopio A
    Oncogene; 2002 Apr; 21(18):2896-900. PubMed ID: 11973650
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis.
    Niu G; Wright KL; Huang M; Song L; Haura E; Turkson J; Zhang S; Wang T; Sinibaldi D; Coppola D; Heller R; Ellis LM; Karras J; Bromberg J; Pardoll D; Jove R; Yu H
    Oncogene; 2002 Mar; 21(13):2000-8. PubMed ID: 11960372
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Notch4 intracellular domain binding to Smad3 and inhibition of the TGF-beta signaling.
    Sun Y; Lowther W; Kato K; Bianco C; Kenney N; Strizzi L; Raafat D; Hirota M; Khan NI; Bargo S; Jones B; Salomon D; Callahan R
    Oncogene; 2005 Aug; 24(34):5365-74. PubMed ID: 16007227
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TGF-beta signaling is disrupted in endometrioid-type endometrial carcinomas.
    Piestrzeniewicz-Ulanska D; Brys M; Semczuk A; Rechberger T; Jakowicki JA; Krajewska WM
    Gynecol Oncol; 2004 Oct; 95(1):173-80. PubMed ID: 15385128
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glycated albumin activates PAI-1 transcription through Smad DNA binding sites in mesangial cells.
    Lee HS; Moon KC; Song CY; Kim BC; Wang S; Hong HK
    Am J Physiol Renal Physiol; 2004 Oct; 287(4):F665-72. PubMed ID: 15198928
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sphingosylphosphorylcholine induces differentiation of human mesenchymal stem cells into smooth-muscle-like cells through a TGF-beta-dependent mechanism.
    Jeon ES; Moon HJ; Lee MJ; Song HY; Kim YM; Bae YC; Jung JS; Kim JH
    J Cell Sci; 2006 Dec; 119(Pt 23):4994-5005. PubMed ID: 17105765
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acceleration of Smad2 and Smad3 phosphorylation via c-Jun NH(2)-terminal kinase during human colorectal carcinogenesis.
    Yamagata H; Matsuzaki K; Mori S; Yoshida K; Tahashi Y; Furukawa F; Sekimoto G; Watanabe T; Uemura Y; Sakaida N; Yoshioka K; Kamiyama Y; Seki T; Okazaki K
    Cancer Res; 2005 Jan; 65(1):157-65. PubMed ID: 15665291
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
    Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
    Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
    López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS
    Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Triptolide inhibits vascular endothelial growth factor expression and production in endothelial cells.
    Hu KB; Liu ZH; Guo XH; Liu D; Li LS
    Acta Pharmacol Sin; 2001 Jul; 22(7):651-6. PubMed ID: 11749832
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
    Sohn BH; Park IY; Lee JJ; Yang SJ; Jang YJ; Park KC; Kim DJ; Lee DC; Sohn HA; Kim TW; Yoo HS; Choi JY; Bae YS; Yeom YI
    Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DPC4/SMAD4 mediated tumor suppression of colon carcinoma cells is associated with reduced urokinase expression.
    Schwarte-Waldhoff I; Klein S; Blass-Kampmann S; Hintelmann A; Eilert C; Dreschers S; Kalthoff H; Hahn SA; Schmiegel W
    Oncogene; 1999 May; 18(20):3152-8. PubMed ID: 10340387
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Independent regulation of growth and SMAD-mediated transcription by transforming growth factor beta in human melanoma cells.
    Rodeck U; Nishiyama T; Mauviel A
    Cancer Res; 1999 Feb; 59(3):547-50. PubMed ID: 9973198
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction.
    Masuda M; Suzui M; Lim JT; Deguchi A; Soh JW; Weinstein IB
    J Exp Ther Oncol; 2002; 2(6):350-9. PubMed ID: 12440226
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The constitutive photomorphogenesis 9 signalosome directs vascular endothelial growth factor production in tumor cells.
    Pollmann C; Huang X; Mall J; Bech-Otschir D; Naumann M; Dubiel W
    Cancer Res; 2001 Dec; 61(23):8416-21. PubMed ID: 11731421
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rapid tumor development and potent vascularization are independent events in carcinoma producing FGF-1 or FGF-2.
    Billottet C; Janji B; Thiery JP; Jouanneau J
    Oncogene; 2002 Nov; 21(53):8128-39. PubMed ID: 12444548
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of IL-6 receptor in pancreatic cancer: involvement in VEGF induction.
    Masui T; Hosotani R; Doi R; Miyamoto Y; Tsuji S; Nakajima S; Kobayashi H; Koizumi M; Toyoda E; Tulachan SS; Imamura M
    Anticancer Res; 2002; 22(6C):4093-100. PubMed ID: 12553038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.